Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study

被引：0
|
作者：
Lange, T. J. [1 ]
Escribano, P. [2 ]
Biedermann, P. [3 ]
Muller, A. [3 ]
Sun, H. [3 ]
Soderberg, S. [4 ]
Gaine, S. [5 ]
机构：
[1] Univ Med Ctr Regensburg, Internal Med 2, Regensburg, Germany
[2] Hosp 12 Octubre, CIBERCV, Dept Cardiol, Pulm Hypertens Unit, Madrid, Spain
[3] Actel Pharmaceut Ltd, Allschwil, Switzerland
[4] Umea Univ, Cardiol & Heart Ctr, Dept Publ Hlth & Clin Med, Umea, Sweden
[5] Mater Misericordiae Univ Hosp, Dublin, Ireland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2910
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    PNEUMOLOGIE, 2021, 75 : S22 - S22
  • [2] REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE)
    Muller, A.
    Soderberg, S.
    Escribano, P.
    Biedermann, P.
    Sun, H.
    Lange, T. J.
    Gaine, S.
    VALUE IN HEALTH, 2019, 22 : S602 - S603
  • [3] Real-world experience of elderly patients with pulmonary arterial hypertension (PAH) initiating selexipag (EXPOSURE/EXTRACT studies)
    Gaine, Sean
    Escribano-Subias, Pilar
    Muller, Audrey
    Fontana, Martina
    Remenova, Tatiana
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] SELEXIPAG TITRATION AND DOSING PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN A REAL-WORLD CLINICAL SETTING: INSIGHTS FROM THE EXPOSURE STUDY
    Johnson, M. K.
    Lange, T. J.
    Soederberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S.
    THORAX, 2021, 76 : A50 - A51
  • [5] Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study
    Lange, T. J.
    Soderberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE
    Soderberg, S.
    Subias, P. Escribano
    O'Donovan, C.
    Muller, A.
    Fontana, M.
    Lange, T. J.
    Gaine, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S85 - S85
  • [7] CONTEMPORARY TREATMENT PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: INSIGHT FROM THE OBSERVATIONAL EXPOSURE STUDY
    Soderberg, Stefan
    Gaine, Sean
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Lange, Tobias
    Escribano-Subias, Pilar
    CHEST, 2020, 158 (04) : 2259A - 2260A
  • [8] BUDGET-IMPACT OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Bilir, S. P.
    Beaudet, A.
    Zervoudaki, A.
    Lamprou, C.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A641 - A642
  • [9] Risk status at selexipag initiation in pulmonary arterial hypertension (PAH): Insights from EXPOSURE
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] COST-EFFECTIVENESS OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Beaudet, A.
    Zervoudaki, A.
    Lamprou, C.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A645 - A645
12345